Welcure Drugs & Pharmaceuticals Ltd Share Price Live
Live Welcure Drugs & Pharmaceuticals Share Price Chart
Welcure Drugs & Pharmaceuticals Performance
Days Range
| Previous Close | ₹0.55 |
|---|---|
| Open | ₹0.57 |
| Volume | 1,44,49,711 |
| Day's Range | ₹0.55 - ₹0.57 |
|---|---|
| 52W Range | ₹0.48 - ₹1.44 |
| Market Cap | ₹67.98 Cr |
Welcure Drugs & Pharmaceuticals Fundamentals
| ROCE(TTM) | 17.53 |
|---|---|
| P/E Ratio (TTM) | 1.96 |
| P/B Ratio | 0.51 |
| Industry P/E | 40.36 |
| Debt to Equity | 0.92 |
| ROE | 25.60 |
| EPS (TTM) | 0.28 |
| Dividend Yield | 0 |
| Book Value | 1.09 |
| Face Value | 1 |
| ROCE(TTM) | 17.53 |
|---|---|
| P/E Ratio (TTM) | 1.96 |
| P/B Ratio | 0.51 |
| Industry P/E | 40.36 |
| Debt to Equity | 0.92 |
| ROE | 25.60 |
|---|---|
| EPS (TTM) | 0.28 |
| Dividend Yield | 0 |
| Book Value | 1.09 |
| Face Value | 1 |
Welcure Drugs & Pharmaceuticals Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 0.88 | 21.21 | 299.91 | 65.62 |
| Expenses | 0.79 | 20.58 | 268.78 | 54.26 |
| Profit before tax | 0.09 | 2.54 | 31.14 | 11.36 |
| Operating Profit | 0.04 | 2.54 | 23.30 | 8.50 |
| Net Profit | 0.04 | 2.54 | 23.30 | 8.50 |
| ESP in Rs | 0.04 | 0.33 | 2.07 | 0.76 |
Welcure Drugs & Pharmaceuticals Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 0% | 0% | 0% | 0% | 0% |
| Flls | 0% | 0% | 0% | 0% | 0% |
| Dlls | 0% | 0% | 0% | 0% | 0% |
| Public | 100% | 100% | 100% | 100% | 100% |
About Welcure Drugs & Pharmaceuticals
Incorporated on 4 Jun.'92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. The company is managed by managing director D C Jain.
WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes.
Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin.
The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups.
The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market.
The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, Saccharin and Aspartame.
The Company has added a new liquid oral plant in Bhiwadi, Rajasthan. It has obtained ISO 9002 certification with double accredition from ABS Quality Evaluation Inc Texas and by Registrar of Accredition Board of USA. Welcure has also entered into an agreement with Bihar Drugs and Chemicals Ltd, a government of Bihar undertaking, for manufacturing their products in its factory on loan basis.
During the year 2000-01 the company had launched some products like CEZEN,DIMCIN PLUS,OXIN,SPASWIN etc.The company has entered into technical collaboration agreement with Advanced Medical Care Inc New Jersey USA for setting up of joint venture facilities in the existing plant of the company.
During the year 2001-02, the company had launched products like B-ZEX, DMART PLUS, DRALPIN, DUKESPAS, DUBAMOL, HISTACURE, KUFFWEL, KINGSPAS, LANAX, PETRIMAX, PEEROSCAM, RENACT, SARVO, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF, X-DRYL.
The company has changed its marketing policy from "Sales through Wholesale Distributors" to " Sales at Doorstep" by reaching every corner of the country and by putting dual force on Sales-through sales personnel on one hand and through stockists and distributors on the other hand.
Parent Organisation
Indian Private
Managing Director
None
Founded
1996
NSE Symbol
Top Mutual Funds Invested in Welcure Drugs Pharmaceuticals Share
Top Mutual Funds Invested in Welcure Drugs Pharmaceuticals Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,799.9 -7.50 (-0.41%) | ₹4,33,763.77 | 1,548.0 - 1,910.0![]() |
| Divis Laboratories Ltd | 6,410.5 -12.00 (-0.19%) | ₹1,70,489.23 | 4,955.0 - 7,071.5![]() |
| Torrent Pharmaceuticals Ltd | 3,726.9 -10.00 (-0.27%) | ₹1,26,435.85 | 2,886.45 - 3,882.2![]() |
| Cipla Ltd | 1,514.8 -8.30 (-0.54%) | ₹1,23,088.18 | 1,335.0 - 1,673.0![]() |
| Dr Reddys Laboratories Ltd | 1,273.8 13.70 (1.09%) | ₹1,05,162.27 | 1,020.0 - 1,405.9![]() |
| Lupin Ltd | 2,080.2 -1.70 (-0.08%) | ₹95,296.58 | 1,795.2 - 2,402.9![]() |
Popular stocks
Welcure Drugs Pharmaceuticals Ltd FAQs
What is the share price of Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares?
Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) share price as of December 2, 2025, on NSE is Rs 0.57 (NSE) and Rs 0.57 (BSE) on BSE.
Can I buy Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) from Angel One?
Yes, You can buy Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
How do I buy Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) from Angel One?
Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares.
1. Direct investment: You can buy Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares.




